| The incidence of neurodegenerative diseases,including Alzheimer’s disease,Parkinson’s disease,multiple sclerosis,etc,is becoming higher and higher.The progress of these diseases are related to oxidative stress,immune inflammation,mitochondrial dysfunction,excitotoxin and apoptosis,etc.Studies found that microglia-mediated inflammatory response plays an important role in the development and progression of neurodegenerative diseases.The microglia could be activated by cytotoxins,external chemical,or physical stimulator,and release a large number of inflammatory factors,which aggravate inflammation and progression of neurodegenerative diseases.Microglia-induced neuroinflammation activates many related signaling pathways,such as Toll-like receptors,JAK/STAT,Nuclear factor kappa B(NF-κB),MAPK,etc.NF-κB is an important signaling pathway that mediates the occurrence of inflammation.Activation of NF-κB can induce a large number of inflammatory factors,which will stimulate microglia in return,then lead to a vicious circle of further inflammation.In the progress of the activation of microglia cells,NF-κB will coordinate with other inflammatory-related channels to trigger a variety of signal cascades,which together regulate the inflammatory response.Therefore,It’s a potential method against neurodegenerative disease to discover effective compounds which can regulate the activation of NF-κB signaling pathway.Researches showed that hemp seed extracts have potential neuroprotective activities.Previous work in our laboratory provided a series of lignanamides isolated from hemp seed.In this study,the anti-neuroinflammatory activity of these compounds were screened by establishing neuroinflammatory model using LPS-stimulated BV2 microglia cells.Grossamide and cannabisin F were selected for further mechanism study involving LPS-induced activation of NF-κB signaling pathway to prove their potential against neuroinflammation related diseases.Results showed that grossamide had potential anti-inflammatory activity.ELISA and qRT-PCR tests revealed that grossamide could inhibit the expression of LPS-induced inflammatory factors in BV2 cells.Wetsern blot and immunofluorescence analysis showed that grossamide could inhibit the phosphorylation of IKBa and NF-κKBp65 protein,and prevent the expression of NF-κBp65 into the nucleus.Meanwhile,grossamide coud prevent the expression of NF-κB upstream protein TLR4 and MyD88.Thus,grossamide can inhibit TLR4-mediated NF-κB signaling pathway in BV2 microglia cells.Cannabisin F also showed potential anti-inflammatory activity.The production of intracellular ROS in BV2 microglia cells was inhibited by cannabisin F dose-dependently.Western blot results showed that cannabisin F could promote the expression of SIRT1,Nrf-2 and the downstream protein HO-1.It could also inhibit the phosphorylation of IκBα and NF-KBp65 protein.The results of ELISA and qRT-PCR revealed that cannabisin F inhibited the production of IL-6 and TNF-a in BV2 microglia cells.Thus,cannabisin F can play a neuroprotective role through activating the SIRTl/Nrf-2 signaling pathway and inhibiting NF-κB signaling pathway. |